FERMENTA BIOTECH LIMITED (FERMENTA.BO)
INR 291.1
(-0.05%)
INR 291.1
(-0.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.06 Billion INR | 1605.78% |
| 2022 | -70.92 Million INR | -119.24% |
| 2021 | 368.64 Million INR | -36.78% |
| 2020 | 583.09 Million INR | 31.34% |
| 2019 | 443.97 Million INR | -64.7% |
| 2018 | 1.25 Billion INR | 66.3% |
| 2017 | 756.21 Million INR | 5614.2% |
| 2016 | -13.71 Million INR | -111.07% |
| 2015 | 123.83 Million INR | 47.91% |
| 2014 | 83.72 Million INR | -50.17% |
| 2013 | 168.01 Million INR | 23.84% |
| 2012 | 135.67 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 331.63 Million INR | 3161.02% |
| 2023 Q3 | 187.33 Million INR | 194.39% |
| 2023 Q4 | -10.83 Million INR | -105.78% |
| 2023 FY | 37.56 Million INR | 152.97% |
| 2023 Q1 | 49.88 Million INR | -62.56% |
| 2023 Q2 | -198.48 Million INR | -497.86% |
| 2022 FY | -70.92 Million INR | -119.24% |
| 2022 Q3 | -161.5 Million INR | -181.02% |
| 2022 Q1 | -17.35 Million INR | -115.39% |
| 2022 Q4 | 133.25 Million INR | 182.5% |
| 2022 Q2 | -57.47 Million INR | -231.19% |
| 2021 Q4 | 112.73 Million INR | 351.97% |
| 2021 Q1 | 198.29 Million INR | 425.89% |
| 2021 FY | 368.64 Million INR | -36.78% |
| 2021 Q2 | 92.62 Million INR | -53.29% |
| 2021 Q3 | -44.74 Million INR | -148.3% |
| 2020 Q4 | 37.7 Million INR | -78.08% |
| 2020 Q3 | 172.02 Million INR | -22.3% |
| 2020 Q2 | 221.4 Million INR | 21.38% |
| 2020 FY | 583.09 Million INR | 31.34% |
| 2020 Q1 | 182.4 Million INR | 200.8% |
| 2019 Q2 | 118.75 Million INR | -43.49% |
| 2019 Q4 | 60.64 Million INR | -39.22% |
| 2019 Q1 | 210.16 Million INR | -25.36% |
| 2019 Q3 | 99.77 Million INR | -15.99% |
| 2019 FY | 443.97 Million INR | -64.7% |
| 2018 Q2 | 437.28 Million INR | 89.89% |
| 2018 FY | 1.25 Billion INR | 66.3% |
| 2018 Q4 | 281.58 Million INR | -32.61% |
| 2018 Q3 | 417.81 Million INR | -4.45% |
| 2018 Q1 | 230.28 Million INR | -38.66% |
| 2017 Q3 | 363.97 Million INR | 247.41% |
| 2017 Q4 | 375.4 Million INR | 3.14% |
| 2017 Q2 | 104.76 Million INR | 1265.14% |
| 2017 FY | 756.21 Million INR | 5614.2% |
| 2017 Q1 | -8.99 Million INR | -211.43% |
| 2016 FY | -13.71 Million INR | -111.07% |
| 2016 Q1 | 43.76 Million INR | 176.6% |
| 2016 Q2 | -7.34 Million INR | -116.79% |
| 2016 Q3 | -26.2 Million INR | -256.72% |
| 2016 Q4 | 8.07 Million INR | 130.79% |
| 2015 Q2 | 39.89 Million INR | -2.72% |
| 2015 Q4 | 15.82 Million INR | -41.62% |
| 2015 Q3 | 27.1 Million INR | -32.05% |
| 2015 FY | 123.83 Million INR | 47.91% |
| 2015 Q1 | 41.01 Million INR | -42.4% |
| 2014 Q3 | -24.04 Million INR | -266.91% |
| 2014 Q1 | 22.17 Million INR | -49.07% |
| 2014 FY | 83.72 Million INR | -50.17% |
| 2014 Q2 | 14.4 Million INR | -35.01% |
| 2014 Q4 | 71.19 Million INR | 396.04% |
| 2013 Q2 | 14.42 Million INR | -52.09% |
| 2013 Q4 | 43.53 Million INR | -45.55% |
| 2013 Q3 | 79.94 Million INR | 454.27% |
| 2013 Q1 | 30.1 Million INR | 73.35% |
| 2013 FY | 168.01 Million INR | 23.84% |
| 2012 FY | 135.67 Million INR | 0.0% |
| 2012 Q4 | 17.36 Million INR | -27.6% |
| 2012 Q3 | 23.98 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 9.28 Million INR | -11404.32% |
| Biocon Limited | 50.83 Billion INR | 97.899% |
| Blue Jet Healthcare Limited | 3.37 Billion INR | 68.331% |
| Concord Biotech Limited | 6.26 Billion INR | 82.945% |
| Dishman Carbogen Amcis Limited | -13.9 Million INR | 7783.065% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.27 Million INR | -83611.229% |
| Lyka Labs Limited | 29.13 Million INR | -3566.138% |
| Panacea Biotec Limited | -309.7 Million INR | 444.832% |
| SAMSRITA LABS LIMITED | -1.49 Million INR | 71420.974% |
| Servoteach Industries Limited | -785.00 INR | 136044176.433% |
| SMS Lifesciences India Limited | 359.47 Million INR | -197.087% |
| Supriya Lifescience Limited | 1.57 Billion INR | 32.049% |
| Syngene International Limited | 14.02 Billion INR | 92.385% |
| TAKE Solutions Limited | -213.49 Million INR | 600.232% |
| Titan Biotech Limited | 315.89 Million INR | -238.067% |
| Transgene Biotek Limited | -7.08 Million INR | 15164.833% |
| Vanta Bioscience Limited | -31.83 Million INR | 3454.312% |